Afinitor Approved In Europe For Advanced Breast Cancer

[News]

E.U. approval has been granted to Novartis drug Afinitor® (everolimus) after successful completion of the Phase III BOLERO-2 (Breast cancer trials of OraL EveROlimus-2) trial...

More... (http://www.medicalnewstoday.com/articles/248628.php)